Dana Small Cap Equity
As of: August 29, 2018
Dana Epiphany Small Cap Equity Fund
Fund Information
as of 12/31/25
| SYMBOL | DSCIX |
| INCEPTION DATE | 11/2/15 |
| BENCHMARK | S&P 500 Index |
| TOTAL FUND AUM | $29.3 MM |
| TOTAL FIRM AUM | $10.8BN |
| MIN. INVESTMENT | $5,000 |
| NET EXPENSE RATIO | 0.95% |
| GROSS EXPENSE RATIO | 1.47% |
| NUMBER OF HOLDINGS | 60 – 65 |
| TARGET CASH POSITION | 0 – 1% |
| INDIVIDUAL SECURITY LIMIT | < 4% |
| SECTOR LIMITS | SECTOR NEUTRAL |
Data source: Morningstar Direct; The Adviser has contractually agreed to waive its management fee and/or reimburse certain operating expenses through 2/28/2026, so that Total Annual Operating Expenses does not exceed 0.95% for the Small Cap Fund.
Top Holdings
as of 12/31/25, subject to change. Current and future portfolio holdings are subject to risk.
| Axsome Therapeutics, Inc. | 2.53% |
| Exlservice Holdings, Inc. | 2.18% |
| Ensign Group | 2.04% |
| Applied Industrial Technologies | 2.01% |
| SkyWest, Inc. | 2.00% |
| Livanova Plc | 2.00% |
| Clean Harbors, Inc. | 2.00% |
| MYR Group, Inc. | 1.98% |
| SPX Technologies | 1.97% |
| Enpro Industries, Inc. | 1.94% |